AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Isracann Biosciences Inc.

$0 +$0.00 (+900.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
1.76K
AVG Volume
56.03K
Trailing/Forward PE
-0.47/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (CAD)
00.250.50.75120 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Revenue (CAD) by quarter
PeriodRevenue (CAD)
23 Q10
22 Q40
22 Q30
22 Q20
22 Q10
21 Q40
21 Q30
21 Q20
21 Q10
20 Q40
Net Income (CAD)
-30M-20M-10M020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Net Income (CAD) by quarter
PeriodNet Income (CAD)
23 Q1-316K
22 Q4-2.73M
22 Q3-620.14K
22 Q2-873.94K
22 Q1-468.84K
21 Q4-21.25M
21 Q3-1.66M
21 Q2-1.34M
21 Q1-250.43K
20 Q4-15.79M
Operating Income (CAD)
-4M-3M-2M-1M020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Operating Income (CAD) by quarter
PeriodOperating Income (CAD)
23 Q1-306K
22 Q4-537.73K
22 Q3-590.45K
22 Q2-902.13K
22 Q1-516.93K
21 Q4-1.03M
21 Q3-1.91M
21 Q2-1.12M
21 Q1-878.99K
20 Q4-3.15M
EBITDA (CAD)
-30M-20M-10M020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF EBITDA (CAD) by quarter
PeriodEBITDA (CAD)
23 Q1-305.56K
22 Q4-2.72M
22 Q3-609.71K
22 Q2-863.51K
22 Q1-444.26K
21 Q4-21.03M
21 Q3-1.84M
21 Q2-1.1M
21 Q1-208.45K
20 Q4-3.35M
Cash Flows (CAD)
-1.5M-1M-500K020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Cash Flows (CAD) by quarter
PeriodCash Flows (CAD)
23 Q1-163.4K
22 Q4-215.23K
22 Q3-521.63K
22 Q2-574.97K
22 Q1-442.73K
21 Q4-1.28M
21 Q3-957.18K
21 Q2-1.28M
21 Q1-890.76K
20 Q4-1.44M
EPS (CAD)
-0.15-0.1-0.05-020 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF EPS (CAD) by quarter
PeriodEPS (CAD)
23 Q1-0
22 Q4-0.02
22 Q3-0
22 Q2-0.01
22 Q1-0
21 Q4-0.15
21 Q3-0.01
21 Q2-0.01
21 Q1-0
20 Q40
Expenses (CAD)
-1M01M2M3M4MSG&ACapex20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Expenses (CAD) by quarter
PeriodExpenses (CAD)
23 Q1295.57K
22 Q4527.3K
22 Q3580.02K
22 Q2891.7K
22 Q1506.5K
21 Q41.03M
21 Q31.9M
21 Q21.11M
21 Q1869.15K
20 Q43.08M
Cash & Debt (CAD)
01M2M3M4MCashLong Term DebtShort Term Debt20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Cash & Debt (CAD) by quarter
PeriodCash & Debt (CAD)
23 Q1198.05K
22 Q4213.94K
22 Q3310.61K
22 Q2826.68K
22 Q11.4M
21 Q41.96M
21 Q32.32M
21 Q22.02M
21 Q13.3M
20 Q43.89M
Debt ratios
00.10.20.30.420 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Debt ratios by quarter
PeriodDebt ratios
23 Q10.04
22 Q40.05
22 Q30.01
22 Q20.03
22 Q10.06
21 Q40.08
21 Q30.36
21 Q20.21
21 Q10.3
20 Q40.33
Margins
0%25%50%75%100%17 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q319 Q4
ISCNF Margins by quarter
PeriodMargins
19 Q4100%
19 Q3100%
19 Q250.36%
19 Q162.32%
18 Q4100%
18 Q33.31%
18 Q264.04%
18 Q162.54%
17 Q459.44%
17 Q338.47%
Return on Capital
-1000%-750%-500%-250%0%20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Return on Capital by quarter
PeriodReturn on Capital
23 Q1-253.06%
22 Q4-940.24%
22 Q3-30.52%
22 Q2-33.11%
22 Q1-13.52%
21 Q4-539.96%
21 Q3-6.73%
21 Q2-5.49%
21 Q1-0.97%
20 Q4-59.45%
Shares Outstanding
050M100M150M200M20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Shares Outstanding by quarter
PeriodShares Outstanding
23 Q1158.47M
22 Q4152.78M
22 Q3146.08M
22 Q2146.09M
22 Q1146.08M
21 Q4145.68M
21 Q3135.98M
21 Q2135.16M
21 Q1155.07M
20 Q40
Book Value Per Share (CAD)
00.10.20.30.420 Q321 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Book Value Per Share (CAD) by quarter
PeriodBook Value Per Share (CAD)
23 Q10
22 Q40
22 Q30.01
22 Q20.02
22 Q10.02
21 Q40.03
21 Q30.18
21 Q20.18
21 Q10.17
20 Q30.39
Total Assets (CAD)
010M20M30M20 Q421 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q1
ISCNF Total Assets (CAD) by quarter
PeriodTotal Assets (CAD)
23 Q14.04M
22 Q44.09M
22 Q32.78M
22 Q23.41M
22 Q13.93M
21 Q44.4M
21 Q325.81M
21 Q225.4M
21 Q127.01M
20 Q428.27M
Free Cash Flow Yield
-800000%-600000%-400000%-200000%0%med -67455.97%Jan 25May 25Sep 25Jan 26May 26Sep 26
ISCNF Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-67541.8%
Sep 26-673034.96%
Aug 26-669655.57%
Aug 26-676379.81%
Aug 26-67105.06%
Aug 26-668002.54%
Jul 26-66437.93%
Jul 26-660602.83%
Jul 26-66400.96%
Jul 26-65786.71%
Jul 26-65645.68%
Jun 26-656146.82%
Jun 26-658504.67%
Jun 26-665538.24%
Jun 26-66792.59%
May 26-67521.71%
May 26-67385.34%
May 26-67730.01%
May 26-68078.21%
May 26-68523.21%
Apr 26-68123.55%
Apr 26-68006.6%
Apr 26-67268.48%
Apr 26-66887.13%
Mar 26-67020.04%
Mar 26-678588.67%
Mar 26-67849.96%
Mar 26-68655.61%
Feb 26-682609.2%
Feb 26-68083.19%
Feb 26-68381.26%
Feb 26-68099.63%
Jan 26-68371.22%
Jan 26-67966.87%
Jan 26-66907.8%
Jan 26-66924.15%
Jan 26-678143.77%
Dec 25-68095.15%
Dec 25-674766.82%
Dec 25-676065.43%
Dec 25-673877.82%
Nov 25-66635.76%
Nov 25-66037.32%
Nov 25-66407.12%
Nov 25-66281.82%
Oct 25-66486.8%
Oct 25-66528.14%
Oct 25-66412.81%
Oct 25-66513.4%
Oct 25-66760.49%
Sep 25-66790.19%
Sep 25-67597.71%
Sep 25-67246.13%
Sep 25-67343.42%
Aug 25-67764.03%
Aug 25-67359.5%
Aug 25-67390.22%
Aug 25-67683.72%
Aug 25-67522.2%
Jul 25-679643.94%
Jul 25-67860.35%
Jul 25-68027.47%
Jul 25-68541.87%
Jun 25-68063.28%
Jun 25-67792.65%
Jun 25-68561.56%
Jun 25-68010.07%
May 25-67777.84%
May 25-67816.35%
May 25-66660.1%
May 25-66828.55%
May 25-674004.68%
Apr 25-67225.73%
Apr 25-67300.58%
Apr 25-67153.47%
Apr 25-65440.79%
Mar 25-65047.54%
Mar 25-64877.08%
Mar 25-64787.68%
Mar 25-64821.52%
Feb 25-64387.52%
Feb 25-65490.51%
Feb 25-65654.94%
Feb 25-65167.3%
Jan 25-64104.2%
Jan 25-649223.3%
Jan 25-64299.46%
Jan 25-64577.35%
Jan 25-64458.85%
Dec 24-646064.79%
Dec 24-64786.33%
Dec 24-654315.89%
Dec 24-657890.37%
Nov 24-664986.75%
Nov 24-66631.95%
Nov 24-6610.2%
Nov 24-6695.79%
Nov 24-6676.1%
Aug 24-683747.32%
Aug 24-6808.77%
Price to Sales
050010001500med 105.65Jan 20Mar 20Apr 20May 20Jun 20Jul 20Aug 20
ISCNF Price to Sales by quarter
PeriodPrice to Sales
Aug 20737.74
Aug 20760.54
Aug 20807.08
Aug 20768.77
Jul 20880.34
Jul 20901.42
Jul 201032.73
Jul 20812.04
Jul 201190.19
Jun 201288.54
Jun 201295.34
Jun 201243.38
Jun 201436.32
May 201100.34
May 20140.48
May 20117.41
May 2071.07
May 2066.8
Apr 2072.74
Apr 2076.33
Apr 2075.42
Apr 2081.41
Mar 20105.65
Mar 2060.29
Mar 2080.73
Mar 20113.57
Feb 2089.74
Feb 2019.56
Feb 2020.94
Feb 2021.23
Jan 2019.58
Jan 2022.17
Jan 2022.24
Jan 2024.2
Jan 2029.15
Price to Book
00.050.10.150.2med 0.02Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ISCNF Price to Book by quarter
PeriodPrice to Book
Sep 260.02
Sep 260
Aug 260
Aug 260
Aug 260.02
Aug 260
Jul 260.02
Jul 260
Jul 260.02
Jul 260.02
Jul 260.02
Jun 260
Jun 260
Jun 260
Jun 260.02
May 260.02
May 260.02
May 260.02
May 260.02
May 260.02
Apr 260.02
Apr 260.02
Apr 260.02
Apr 260.02
Mar 260.02
Mar 260
Mar 260.02
Mar 260.02
Feb 260
Feb 260.02
Feb 260.02
Feb 260.02
Jan 260.02
Jan 260.02
Jan 260.02
Jan 260.02
Jan 260
Dec 250.02
Dec 250
Dec 250
Dec 250
Nov 250.02
Nov 250.02
Nov 250.02
Nov 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Jul 250
Jul 250.02
Jul 250.02
Jul 250.02
Jun 250.02
Jun 250.02
Jun 250.02
Jun 250.02
May 250.02
May 250.02
May 250.02
May 250.02
May 250
Apr 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Feb 250.02
Feb 250.02
Feb 250.02
Feb 250.02
Jan 250.02
Jan 250
Jan 250.02
Jan 250.02
Jan 250.02
Dec 240
Dec 240.02
Dec 240
Dec 240
Nov 240
Nov 240.02
Nov 240.18
Nov 240.18
Nov 240.18
Aug 240
Aug 240.17
Isracann Biosciences Inc.
ISCNF
Stockpicker

Video analysis: ISCNF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.